Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy

BACKGROUND: To evaluate the predictors for resectability and survival of patients with locally advanced pancreatic cancer (LAPC) treated with gemcitabine-based neoadjuvant therapy (GBNAT). METHODS: Between May 2003 and Dec 2009, 41 tissue-proved LAPC were treated with GBNAT. The location of pancreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Ying-Jui, Sy, Edgar D, Hsu, Hui-Ping, Shan, Yan-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182443/
https://www.ncbi.nlm.nih.gov/pubmed/25258022
http://dx.doi.org/10.1186/1471-2482-14-72

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182443/
https://www.ncbi.nlm.nih.gov/pubmed/25258022
http://dx.doi.org/10.1186/1471-2482-14-72

Ejemplares similares